Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx

Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx

Background<p>Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with poor prognosis. Efferocytosis, an essential process for clearing apoptotic cells, is involved in shaping immunosuppressive microenvironment, facilitating tumor immune evasion. This study aims to evaluate the...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Xiangjun Wang (2522917) (author)
Andere auteurs:	Wei Wang (17594) (author), Chuanxin Yang (18266948) (author), Puxiongzhi Wang (3877201) (author), Yangming Liu (12254459) (author), Liqin Yu (1461880) (author), Sijie Zhang (7429373) (author), Xiaoyu Yan (500545) (author), Jian Wang (5901) (author)
Gepubliceerd in:	2025
Onderwerpen:	Genetic Immunology pancreatic ductal adenocarcinoma efferocytosis prognostic signature immunosuppressive microenvironment P2RY6 MRS-2578
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Table 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Table 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Image 9_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Image 8_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Image 6_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Image 7_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Image 4_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Image 5_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Image 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Image 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Image 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
door: Xiangjun Wang (2522917)
Gepubliceerd in: (2025)

Supplementary Data 1 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
door: Gregory L. Beatty (15087193)
Gepubliceerd in: (2025)

Supplementary Data 2 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
door: Gregory L. Beatty (15087193)
Gepubliceerd in: (2025)

Table 1_Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1.docx
door: Marwa Zafarullah (12527002)
Gepubliceerd in: (2025)

Table 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.docx
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Table 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Table 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 9_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 10_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 11_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 7_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 8_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 5_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 6_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 4_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Image 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
door: Jichang Liu (1263291)
Gepubliceerd in: (2025)

Data Sheet 3_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.pdf
door: Ping Liao (5424887)
Gepubliceerd in: (2025)

Data Sheet 1_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.docx
door: Ping Liao (5424887)
Gepubliceerd in: (2025)

Data Sheet 2_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.xls
door: Ping Liao (5424887)
Gepubliceerd in: (2025)

Table 1_Machine learning-based differentiation of lung squamous cell carcinoma and adenocarcinoma using clinical-semantic and radiomic features.docx
door: Yanju Li (9697993)
Gepubliceerd in: (2025)

Table 2_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
door: Rui Wang (52434)
Gepubliceerd in: (2025)

Table 3_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
door: Rui Wang (52434)
Gepubliceerd in: (2025)

Table 1_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.xlsx
door: Rui Wang (52434)
Gepubliceerd in: (2025)

Supplementary Table S1 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
door: Erika Y. Faraoni (14844897)
Gepubliceerd in: (2025)

Supplementary Table S3 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
door: Erika Y. Faraoni (14844897)
Gepubliceerd in: (2025)

Supplementary Table S4 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
door: Erika Y. Faraoni (14844897)
Gepubliceerd in: (2025)

الإثبات بالتوقيع الرقمي في العقود الذكيّة باستخدام تقنية البلوك تشين بين الفقه الإسلامي وقانون المعاملات الإلكترونيّة الأردني وقانون البينات
door: Daoud, Hayel Abdel Hafeez Yousef
Gepubliceerd in: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
door: Hailong Pang (12841991)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_dfhbkcub9dm1c8tbmob4o3pk74